Cancer Immunology Training Grant
癌症免疫学培训补助金
基本信息
- 批准号:9404561
- 负责人:
- 金额:$ 1.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-07-13 至 2021-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Project Summary
This training program is designed to train the next generation of scientists in Cancer Immunology at the Dana-
Farber/Harvard Cancer Center, a Harvard-wide, NCI-designated Comprehensive Cancer Center. Recent
clinical trials have demonstrated that cancer immunotherapy can induce durable responses in patients with
diverse types of advanced cancer. The discovery that targeting of a single inhibitory receptor on immune cells
can unleash durable anti-tumor immunity has far-reaching implications for oncology and raises many
fascinating questions about the biological mechanisms that regulate anti-tumor immunity. The resulting rapid
growth in the field of cancer immunology has created a significant need for scientists with in depth expertise at
the interface of immunology and tumor biology. To address this need, we have built a comprehensive program
supported by faculty who bring a wide spectrum of expertise in basic and translational cancer immunology. The
preceptors of this grant have made a series of important contributions to cancer immunology and
immunotherapy. We propose to appoint 2 predoctoral and 6 postdoctoral scientists per year. Our predoctoral
trainees will be selected from a pool of students who have enrolled in the Immunology and Basic Biomedical
Sciences Graduate Programs at Harvard Medical School. These students will be appointed after their second
year of study once they have chosen one of our mentors as their thesis advisor and committed to a research
topic in cancer immunology. The postdoctoral positions will be awarded to a select group of recent recipients of
PhD and MD/PhD degrees and support their training in cancer immunology. Laboratory training in cancer
immunology will be complemented by a didactic program that gives students the required background in
cancer immunology and prepares them for independent careers in academic research, biotechnology or a
broad range of other job opportunities. The program directors are highly committed to teaching and mentoring
and have the required expertise to lead this effort. The Postdoctoral and Graduate Student Affairs Offices at
Dana-Farber and Harvard Medical School provide a wide range of programs to all of our trainees designed to
enhance their training experience and address individual needs. Retreats organized by the Harvard
Immunology Program and the Department of Cancer Immunology and Virology at Dana-Farber will help to
create a sense of community and give our trainees the opportunity to learn from other trainees and faculty.
项目摘要
该培训计划旨在培养下一代癌症免疫学科学家,
法伯/哈佛癌症中心,一个哈佛范围内的,NCI指定的综合癌症中心。最近
临床试验已经证明,癌症免疫疗法可以在患有癌症的患者中诱导持久的应答。
不同类型的晚期癌症。发现免疫细胞上的单一抑制性受体的靶向
可以释放持久的抗肿瘤免疫力,对肿瘤学具有深远的影响,并提出了许多
关于调节抗肿瘤免疫的生物学机制的有趣问题。由此产生的快速
癌症免疫学领域的发展对具有深入专业知识的科学家产生了重大需求,
免疫学和肿瘤生物学的界面。为了满足这一需求,我们建立了一个全面的计划,
由教师谁带来了基础和转化癌症免疫学的广泛专业知识的支持。的
该基金的导师们对癌症免疫学做出了一系列重要贡献,
免疫疗法我们建议每年任命2名博士前和6名博士后科学家。我们的博士预科生
受训人员将从参加免疫学和基础生物医学的学生中挑选。
哈佛医学院科学研究生课程。这些学生将在他们的第二次
一年的学习,一旦他们选择了我们的导师之一作为他们的论文导师,并致力于研究
癌症免疫学的主题。博士后职位将授予一组精选的最近获奖者,
博士和医学博士/博士学位,并支持他们在癌症免疫学的培训。癌症实验室培训
免疫学将由一个教学计划,为学生提供所需的背景,
癌症免疫学,并准备他们在学术研究,生物技术或
广泛的其他工作机会。项目主任高度致力于教学和指导
并拥有领导这项工作所需的专业知识。博士后及研究生事务处
丹娜法伯和哈佛医学院提供了广泛的计划,以我们所有的学员,旨在
提高他们的培训经验,满足个人需求。哈佛大学组织的静修会
丹娜-法伯大学的免疫学项目和癌症免疫学和病毒学系将帮助
创造一种社区意识,让我们的学员有机会向其他学员和教师学习。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(1)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kai W Wucherpfennig其他文献
Cracking the code of human T-cell immunity
破解人类 T 细胞免疫的密码
- DOI:
10.1038/nbt.2626 - 发表时间:
2013-07-09 - 期刊:
- 影响因子:41.700
- 作者:
Christopher J Harvey;Kai W Wucherpfennig - 通讯作者:
Kai W Wucherpfennig
4-1bb Enrichment Enhances Adoptive T Cell Therapy for Hematological Malignancies Using a Novel Approach for Ex Vivo Immune Cell Priming with DC/Tumor Fusion Vaccine
- DOI:
10.1182/blood-2023-182381 - 发表时间:
2023-11-02 - 期刊:
- 影响因子:
- 作者:
Kathrine S Rallis;Jessica Liegel;Giulia Cheloni;Poorva Bindal;Isabella Saldarriaga;Junyan Zhang;Georges Chedid;Joseph Abirached;John G. Clohessy;Sophia Adamia;Kai W Wucherpfennig;Donald Kufe;Jacalyn Rosenblatt;David Avigan - 通讯作者:
David Avigan
Randomized Phase II Trial of Dendritic Cell/AML Fusion Cell Vaccination Compared to Standard of Care Therapy in AML CR1
- DOI:
10.1182/blood-2024-200876 - 发表时间:
2024-11-05 - 期刊:
- 影响因子:
- 作者:
Prateek Pophali;Giulia Cheloni;Richard M. Stone;Kai W Wucherpfennig;Aric C. Hall;Amir T. Fathi;Lina Bisharat;Emma K Logan;Yiwen Liu;Donna S. Neuberg;Malgorzata McMasters;Jessica Liegel;Jacqueline S. Garcia;Daniel J. DeAngelo;Michele Narcis;Dina Stroopinsky;Pavania Elavalakanar;Ioannis S Vlachos;Ilene A. Galinsky;Jason Pyrdol - 通讯作者:
Jason Pyrdol
Advances in CD137-Enriched Adoptive T Cell Therapy for Acute Myeloid Leukemia Via Ex Vivo Immune Cell Priming with DC/AML Fusion Vaccine
- DOI:
10.1182/blood-2024-208563 - 发表时间:
2024-11-05 - 期刊:
- 影响因子:
- 作者:
Kathrine S Rallis;Jessica Liegel;Giulia Cheloni;Poorva Bindal;Isabella Saldarriaga;Junyan Zhang;Georges Chedid;Joseph Abirached;Jonah Lee;John G. Clohessy;Samprity Ankita;Rajeev Relangi;Lina Bisharat;Hazal Toros;Sophia Adamia;Jasper B Lee;Donald Kufe;Kai W Wucherpfennig;Jacalyn Rosenblatt;David Avigan - 通讯作者:
David Avigan
Kai W Wucherpfennig的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kai W Wucherpfennig', 18)}}的其他基金
Therapeutic Targeting of Immune Evasion from the MICA - NKG2D Pathway
MICA 免疫逃避的治疗靶向 - NKG2D 通路
- 批准号:
10380449 - 财政年份:2021
- 资助金额:
$ 1.02万 - 项目类别:
Core 1: Tumor Processing and Single Cell RNA sequencing Core
核心1:肿瘤处理和单细胞RNA测序核心
- 批准号:
10210225 - 财政年份:2020
- 资助金额:
$ 1.02万 - 项目类别:
Targeting of a Major Immune Evasion Pathway in Triple-negative Breast Cancer
靶向三阴性乳腺癌的主要免疫逃避途径
- 批准号:
10029035 - 财政年份:2020
- 资助金额:
$ 1.02万 - 项目类别:
Proj. 3: Immunosuppressive circuits in T cells and other immune cells in GBM patients enrolled in clinical trials
项目。
- 批准号:
10210221 - 财政年份:2020
- 资助金额:
$ 1.02万 - 项目类别:
Targeting of a Major Immune Evasion Pathway in Triple-negative Breast Cancer
靶向三阴性乳腺癌的主要免疫逃避途径
- 批准号:
10224146 - 财政年份:2020
- 资助金额:
$ 1.02万 - 项目类别:
Proj. 3: Immunosuppressive circuits in T cells and other immune cells in GBM patients enrolled in clinical trials
项目。
- 批准号:
10477984 - 财政年份:2020
- 资助金额:
$ 1.02万 - 项目类别:
Targeting of a Major Immune Evasion Pathway in Triple-negative Breast Cancer
靶向三阴性乳腺癌的主要免疫逃避途径
- 批准号:
10400167 - 财政年份:2020
- 资助金额:
$ 1.02万 - 项目类别:
Targeting of a Major Immune Evasion Pathway in Triple-negative Breast Cancer
靶向三阴性乳腺癌的主要免疫逃避途径
- 批准号:
10668947 - 财政年份:2020
- 资助金额:
$ 1.02万 - 项目类别:
Proj. 3: Immunosuppressive circuits in T cells and other immune cells in GBM patients enrolled in clinical trials
项目。
- 批准号:
10684029 - 财政年份:2020
- 资助金额:
$ 1.02万 - 项目类别:
Core 1: Tumor Processing and Single Cell RNA sequencing Core
核心1:肿瘤处理和单细胞RNA测序核心
- 批准号:
10684050 - 财政年份:2020
- 资助金额:
$ 1.02万 - 项目类别:
相似海外基金
Skeletal, Craniofacial and Oral Biology Training Grant
骨骼、颅面和口腔生物学培训补助金
- 批准号:
10845816 - 财政年份:2023
- 资助金额:
$ 1.02万 - 项目类别:
UNC Immunotherapy Training Grant (IM-TAG)
北卡罗来纳大学免疫治疗培训补助金 (IM-TAG)
- 批准号:
10767617 - 财政年份:2023
- 资助金额:
$ 1.02万 - 项目类别:
Graduate Industrial Hygiene Training Program Grant, University of Arizona
亚利桑那大学研究生工业卫生培训计划补助金
- 批准号:
10730704 - 财政年份:2023
- 资助金额:
$ 1.02万 - 项目类别:
Collaborative Research: Conference: Convenings to Develop GRANTS MADE: Grant and Research Administration Networking and Training for Students at Maryland and Delaware MSIs
合作研究:会议:召开授予赠款的会议:为马里兰州和特拉华州 MSI 的学生提供赠款和研究管理网络和培训
- 批准号:
2324414 - 财政年份:2023
- 资助金额:
$ 1.02万 - 项目类别:
Standard Grant
UF Health Cancer Center Support Grant - Training Navigator Supplement
佛罗里达大学健康癌症中心支持补助金 - 培训导航补充
- 批准号:
10892335 - 财政年份:2023
- 资助金额:
$ 1.02万 - 项目类别:
Collaborative Research: Conference: Convenings to Develop GRANTS MADE: Grant and Research Administration Networking and Training for Students at Maryland and Delaware MSIs
合作研究:会议:召开授予赠款的会议:为马里兰州和特拉华州 MSI 的学生提供赠款和研究管理网络和培训
- 批准号:
2324413 - 财政年份:2023
- 资助金额:
$ 1.02万 - 项目类别:
Standard Grant














{{item.name}}会员




